The researchers at Tata Memorial Centre have created a tablet called "R+Cu" that can stop the spread of cancer in the body and also reduces the side effects of chemo and radiation therapy by up to 50%. It is a groundbreaking development with an affordable price of ₹100. The cost ensures that the tablet can be accessed by a large population. It still has to go through human trials and might take 5-6 years before hitting the market.
Although cancer is a terrible illness, new treatments and medications are being created to prevent and treat it as much as possible, thanks to medical advancements. One such revolution is done by the Tata Memorial Centre in the field of cancer treatment by creating a ₹100 pill that can stop the re-emergence of cancer and the side effects of chemotherapy.
The drug is created by the research team at Tata Memorial Centre and can potentially stop the spread of cancer cells after the chemotreatment. It is a ray of hope especially in India where the cost of cancer treatment is colossal. The developers claim that the medicine can reduce the side effects of chemo and radiation therapy by 50%. It is a bold claim but it instills a sense of optimism for the future of cancer treatment.
How does it work?The drug called “R+Cu”, is a pro-oxidant tablet consisting of resveratrol and copper. These two are responsible for creating oxygen radicals in the body that eliminate chromatin particles in dying cancer cells. If not destroyed these particles can turn the healthy cells into cancer cells. One more advantage of oxygen radicals is that they inhibit the movement of cancerous cells to the other parts of the body, controlling the process of Metastases. The new tablet from the Tata Memorial Centre will soon get approval from the Food Safety and Standards Authority of India (FSSAI) around June, following which human trials can begin, said Dr Badwe, Director of the Tata Memorial Centre.
Accessible by allOne of the best features that stands out to the public is the affordability of the tablet. It is supposed to hit the market with a price of ₹100. This ensures that the medicine will be accessible to all individuals in the country seeking cancer treatment. According to the experts, the tablet can be used to help patients with lung, pancreatic, and oral cancer. The medicine still has some 5-6 years before it becomes available to the public after successfully passing the human trials.
The road to a definitive cure for cancer is long but, it is a significant leap in the field of cancer treatment and research, with its affordable pricing making it obtainable by everyone.
Read Exclusive COVID-19 Coronavirus News updates, at MyNation.